NCT03228667 2026-01-14QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsImmunityBio, Inc.Phase 2 Active not recruiting40 enrolled
NCT04817826 2025-06-10INFINITYGruppo Oncologico del Nord-OvestPhase 2 Active not recruiting31 enrolled